Vahh Chemicals Set for IPO Debut Today: GMP Insights Predict Strong Market Reception.

The upcoming market debut of Vahh Chemicals on the BSE SME platform on June 11 is attracting considerable attention from investors, buoyed by positive grey market signals. Currently, the shares are trading at a grey market premium (GMP) of approximately 5%, forecasting a listing price of around Rs 63, a gain of Rs 3 above the issue price of Rs 60 per share. However, as the GMP is an unofficial indicator, actual market performance upon listing may deviate from these expectations.

The company’s initial public offering (IPO) of Rs 13.45 crore, comprising a fresh issue of 22.42 lakh shares, garnered significant investor interest, with an overall subscription rate of 11.08 times. This robust demand was predominantly driven by retail investors alongside considerable participation from non-institutional investors. Vahh Chemicals, established in 2019, specializes in manufacturing and trading textile auxiliary chemicals, offering a diverse range of 92 stock keeping units (SKUs) catering to various textile substrates, which includes cotton and synthetic blends. Additionally, the company’s subsidiary, HSHS Nutraceuticals, provides further diversification within the nutraceuticals sector.

Vahh Chemicals has demonstrated impressive financial performance, evidenced by an 82% increase in revenue for FY26, rising to Rs 43.19 crore from Rs 23.75 crore in the prior fiscal year. Profit after tax similarly surged by 97%, reaching Rs 5.09 crore, while EBITDA expanded to Rs 8.23 crore from Rs 4.68 crore. These metrics suggest a strong upward trajectory in operational efficiency and profitability. The raised capital from the IPO is earmarked for working capital needs, establishing a new manufacturing facility in Surat, and repaying existing borrowings, which could strengthen the company’s balance sheet.

With solid growth prospects and a reasonable valuation framework, investor sentiment appears cautiously optimistic. As Vahh Chemicals transitions into the public domain, market participants will closely monitor the actual trading performance against the expectations set by grey market indications. The company’s strategic positioning within India’s textile industry, alongside a focus on diversifying product lines in nutraceuticals, is expected to further enhance its market appeal.


Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova team.)